An investigation into the feasibility of incorporating ketoconazole into solid lipid microparticles
One of the major challenges of the oral administration of ketoconazole (KTZ), an inhibitor of sterol 14α demethylase, used in the management of systemic and topical mycoses in immuno-compromised and paediatric patients is the lack of availability of liquid dosage forms. In order to overcome this cha...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | English |
| Published: |
Rhodes University
2015
|
| Online Access: | http://hdl.handle.net/10962/54701 |